Myeloma News
Team Finds Gene That Promotes Drug Resistance In Cancer
Findings could lead to better diagnoses, new therapies ... Read more
Pomalidomide To Be Reviewed By FDA Advisory Committee
The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will review Celgene Corporation’s new drug application for pomalidomide at a meeting on November ... Read more
FDA Approves Kyprolis (Carfilzomib) For Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has approved Kyprolis (carfilzomib) for multiple myeloma patients who have failed to respond to at least two ... Read more
Study Shows No Difference Between Bone Drugs For Multiple Myeloma
Many patients with multiple myeloma have symptoms of bone disease and take drugs called bisphosphonates to treat their bone symptoms and bone damage. Bisphosphonates used in ... Read more
New Studies Very Encouraging For Amyloidosis Patients
Two reports published online February 13 in the journal Blood show some of the best responses ever in amyloidosis, a condition that shares characteristics with ... Read more
Drug Shows Positive Response In Myeloma Patients in Australia
Immune System Therapeutics Limited, an Australian bio-therapeutic company, is recruiting patients for the second stage of a Phase II trial for a breakthrough antibody treatment ... Read more
Study Shows Reason To Be Cautious With Dosage of Myeloma Drug Lenalidomide
An early phase trial reveals that lenalidomide (also known as Revlimid), a drug used to treat multiple myeloma, interacts with P-glycoprotein (Pgp), a molecule that ... Read more
Study: Growing Up Near Livestock Increases Risk of Blood Cancers
A new study published online in the journal Occupational and Environmental Medicine suggests people raised on livestock farms are at an increased risk of developing ... Read more
Benefits Outweigh Risks with Myeloma Drug Revlimid
Concerns about a possible link between Revlimid® (lenalidomide) and secondary cancers were raised during the American Society of Hematology (ASH) annual meeting in December 2010, ... Read more
Tai Chi Can Help Improve Health After Chemotherapy
A study by a University of Missouri health psychologist indicates Tai Chi, a Chinese martial art, might help patients who receive chemotherapy overcome some of ... Read more
Risks Outweigh Benefits of Allogeneic Transplant in Multiple Myeloma
A study presented at the American Society of Hematology 52nd Annual Meeting finds the toxicity associated with allogeneic transplantation outweighs possible benefit of reduced relapse ... Read more
